189 related articles for article (PubMed ID: 29845002)
1. Rituximab for retroperitoneal fibrosis due to IgG4-related disease: A case report and literature review.
Almeqdadi M; Al-Dulaimi M; Perepletchikov A; Tomera K; Jaber BL
Clin Nephrol Case Stud; 2018; 6():4-10. PubMed ID: 29845002
[TBL] [Abstract][Full Text] [Related]
2. IgG4-related kidney disease complicated with retroperitoneal fibrosis: A case report.
He PH; Liu LC; Zhou XF; Xu JJ; Hong WH; Wang LC; Liu SJ; Zeng JH
World J Clin Cases; 2023 Mar; 11(7):1656-1665. PubMed ID: 36926395
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis.
Wallwork R; Wallace Z; Perugino C; Sharma A; Stone JH
Medicine (Baltimore); 2018 Oct; 97(42):e12631. PubMed ID: 30334947
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G4-related retroperitoneal fibrosis.
Angarola E; Valeo Chulvi M; Peuchot V; García Rivello H; Jauk F
Medicina (B Aires); 2022; 82(1):91-98. PubMed ID: 35037866
[TBL] [Abstract][Full Text] [Related]
5. An Interesting Case of Immunoglobulin G4-Related Retroperitoneal Fibrosis Treated With Rituximab.
Hamdan A; Moeen Z; Tariq H; Olson O; Matute-Martinez C; Sidhu M; Mukkera S
Cureus; 2021 Sep; 13(9):e17940. PubMed ID: 34660129
[TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease.
Choi YK; Yang JH; Ahn SY; Ko GJ; Oh SW; Kim MG; Cho WY; Jo SK
Kidney Res Clin Pract; 2019 Mar; 38(1):42-48. PubMed ID: 30754935
[TBL] [Abstract][Full Text] [Related]
7. IgG4-related retroperitoneal fibrosis: a newly characterized disease.
Lian L; Wang C; Tian JL
Int J Rheum Dis; 2016 Nov; 19(11):1049-1055. PubMed ID: 27125330
[TBL] [Abstract][Full Text] [Related]
8. No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases.
Forestier A; Buob D; Mirault T; Puech P; Gnemmi V; Launay D; Hachulla E; Hatron PY; Lambert M
Clin Exp Rheumatol; 2018; 36(3):371-375. PubMed ID: 29465374
[TBL] [Abstract][Full Text] [Related]
9. IgG4-related nephropathy.
Quattrocchio G; Roccatello D
J Nephrol; 2016 Aug; 29(4):487-93. PubMed ID: 26972314
[TBL] [Abstract][Full Text] [Related]
10. IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy.
Quattrocchio G; Barreca A; Demarchi A; Solfietti L; Beltrame G; Fenoglio R; Ferro M; Mesiano P; Murgia S; Del Vecchio G; Massara C; Rollino C; Roccatello D
Oncotarget; 2018 Apr; 9(30):21337-21347. PubMed ID: 29765543
[TBL] [Abstract][Full Text] [Related]
11. Large vessel involvement by IgG4-related disease.
Perugino CA; Wallace ZS; Meyersohn N; Oliveira G; Stone JR; Stone JH
Medicine (Baltimore); 2016 Jul; 95(28):e3344. PubMed ID: 27428181
[TBL] [Abstract][Full Text] [Related]
12. Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges.
Mizushima I; Kawano M
Int J Nephrol Renovasc Dis; 2021; 14():279-289. PubMed ID: 34349543
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Retroperitoneal Fibrosis Patients at a Tertiary Hospital in Japan.
Ando M; Hanayama Y; Nishimura Y; Hagiya H; Otsuka F
Acta Med Okayama; 2023 Oct; 77(5):527-536. PubMed ID: 37899264
[TBL] [Abstract][Full Text] [Related]
14. IgG4-related retroperitoneal fibrosis: A case report of a challenging disease.
Farook S; Jilani MSA; Islam MK; Rahman S; Ashraf R; Mendiratta N; Rawal SK
Clin Case Rep; 2023 Sep; 11(9):e7865. PubMed ID: 37663821
[TBL] [Abstract][Full Text] [Related]
15. A case of IgG4-related retroperitoneal fibrosis with significant involvement of the abdominal aorta-a clinical and diagnostic challenge.
Gormley S; Bravo PT; Kos X; Solanki K; Khashram M
J Vasc Surg Cases Innov Tech; 2022 Jun; 8(2):275-280. PubMed ID: 35586678
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis.
Koo BS; Koh YW; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2015 Mar; 25(2):194-8. PubMed ID: 25036229
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of IgG4 related retroperitoneal fibrosis: a report of 5 cases and literature review].
Dun YJ; Yu LP; Du YQ; Sheng ZZ; Wang GW; Li X; Yang B; Xu T; Huang XB; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):622-7. PubMed ID: 26284398
[TBL] [Abstract][Full Text] [Related]
18. IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study.
Lomborg N; Jakobsen M; Bode CS; Junker P
Scand J Rheumatol; 2019 Jul; 48(4):320-325. PubMed ID: 30931680
[No Abstract] [Full Text] [Related]
19. Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort.
Evans RDR; Cargill T; Goodchild G; Oliveira B; Rodriguez-Justo M; Pepper R; Connolly J; Salama A; Webster G; Barnes E; Culver EL
Kidney Int Rep; 2019 Jan; 4(1):48-58. PubMed ID: 30596168
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin G4-related kidney diseases: An updated review.
Salvadori M; Tsalouchos A
World J Nephrol; 2018 Jan; 7(1):29-40. PubMed ID: 29359118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
